Teaser: EHA 2024 Update zur AML

from OnkoImpuls · host DIGIMED Verlag GmbH

 Interview zum EHA 2024 und einem Studienupdate zur Akuten Myeloischen Leukämie (AML) mit Prof. Dr. Christoph Röllig, Bereichsleiter der Hämatologie und klinischen Studien in der Fachabteilung Hämatologie, Zelltherapie und medizinische Onkologie am Universitätsklinikum Carl Gustav Carus Dresden. Der Experte spricht über die Rolle der molekularen Diagnostik sowie verschiedenen neuen Therapieformen zur Behandlung der AML. ' Ganze Folge hörbar unter: https://www.krebsgesellschaft.de/onko-internetportal/kongresse/eha/2024/podcast-eha-2024-mit-update-zur-aml.html 

Episode metadata supplied by the publisher feed · Published Jul 25, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Teaser: EHA 2024 Update zur AML

0:00 1:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OnkoImpuls?

This episode is 1 minute long.

When was this OnkoImpuls episode published?

This episode was published on July 25, 2024.

Can I download this OnkoImpuls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!